nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—ASIC2—nerve—hypothyroidism	0.0466	0.103	CbGeAlD
Amiloride—PLAU—Endochondral Ossification—THRA—hypothyroidism	0.0165	0.0746	CbGpPWpGaD
Amiloride—ASIC2—pituitary gland—hypothyroidism	0.0144	0.032	CbGeAlD
Amiloride—Angina pectoris—Liothyronine—hypothyroidism	0.014	0.0429	CcSEcCtD
Amiloride—SCNN1D—heart—hypothyroidism	0.0111	0.0247	CbGeAlD
Amiloride—ASIC1—heart—hypothyroidism	0.0109	0.0242	CbGeAlD
Amiloride—SLC9A1—heart—hypothyroidism	0.0105	0.0232	CbGeAlD
Amiloride—Coma—Levothyroxine—hypothyroidism	0.0103	0.0315	CcSEcCtD
Amiloride—Coma—Dextrothyroxine—hypothyroidism	0.0103	0.0315	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—hypothyroidism	0.01	0.0451	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—CLTC—hypothyroidism	0.00997	0.045	CbGpPWpGaD
Amiloride—PLAU—heart—hypothyroidism	0.00993	0.022	CbGeAlD
Amiloride—SLC9A1—cardiovascular system—hypothyroidism	0.00989	0.0219	CbGeAlD
Amiloride—ASIC2—cerebellum—hypothyroidism	0.00986	0.0218	CbGeAlD
Amiloride—SCNN1D—gonad—hypothyroidism	0.00954	0.0211	CbGeAlD
Amiloride—SCNN1B—heart—hypothyroidism	0.00942	0.0208	CbGeAlD
Amiloride—PLAU—cardiovascular system—hypothyroidism	0.00937	0.0208	CbGeAlD
Amiloride—SCNN1G—pituitary gland—hypothyroidism	0.00931	0.0206	CbGeAlD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00903	0.0407	CbGpPWpGaD
Amiloride—SCNN1A—adrenal cortex—hypothyroidism	0.009	0.0199	CbGeAlD
Amiloride—SCNN1D—adrenal gland—hypothyroidism	0.00832	0.0184	CbGeAlD
Amiloride—PLAU—pituitary gland—hypothyroidism	0.0083	0.0184	CbGeAlD
Amiloride—ASIC1—adrenal gland—hypothyroidism	0.00816	0.0181	CbGeAlD
Amiloride—AOC1—blood—hypothyroidism	0.00816	0.0181	CbGeAlD
Amiloride—SCNN1B—gonad—hypothyroidism	0.00806	0.0179	CbGeAlD
Amiloride—SCNN1G—thyroid gland—hypothyroidism	0.00803	0.0178	CbGeAlD
Amiloride—PLAU—Osteopontin-mediated events—VAV3—hypothyroidism	0.00786	0.0355	CbGpPWpGaD
Amiloride—SLC9A1—adrenal gland—hypothyroidism	0.00782	0.0173	CbGeAlD
Amiloride—SLC9A1—blood—hypothyroidism	0.00782	0.0173	CbGeAlD
Amiloride—ASIC1—female gonad—hypothyroidism	0.00761	0.0169	CbGeAlD
Amiloride—Coma—Liotrix—hypothyroidism	0.00758	0.0232	CcSEcCtD
Amiloride—SLC9A1—thyroid gland—hypothyroidism	0.00755	0.0167	CbGeAlD
Amiloride—PLAU—adrenal gland—hypothyroidism	0.00741	0.0164	CbGeAlD
Amiloride—PLAU—blood—hypothyroidism	0.00741	0.0164	CbGeAlD
Amiloride—PLAU—FGF signaling pathway—BGLAP—hypothyroidism	0.00739	0.0333	CbGpPWpGaD
Amiloride—SLC9A1—female gonad—hypothyroidism	0.00729	0.0161	CbGeAlD
Amiloride—SCNN1A—pituitary gland—hypothyroidism	0.00727	0.0161	CbGeAlD
Amiloride—Muscular weakness—Levothyroxine—hypothyroidism	0.00722	0.0221	CcSEcCtD
Amiloride—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00722	0.0221	CcSEcCtD
Amiloride—PLAU—thyroid gland—hypothyroidism	0.00715	0.0158	CbGeAlD
Amiloride—SCNN1B—adrenal gland—hypothyroidism	0.00703	0.0156	CbGeAlD
Amiloride—PLAU—female gonad—hypothyroidism	0.00691	0.0153	CbGeAlD
Amiloride—Angina pectoris—Levothyroxine—hypothyroidism	0.00689	0.0211	CcSEcCtD
Amiloride—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00689	0.0211	CcSEcCtD
Amiloride—SCNN1D—testis—hypothyroidism	0.00688	0.0152	CbGeAlD
Amiloride—SCNN1B—thyroid gland—hypothyroidism	0.00678	0.015	CbGeAlD
Amiloride—AOC1—testis—hypothyroidism	0.00675	0.0149	CbGeAlD
Amiloride—ASIC1—testis—hypothyroidism	0.00675	0.0149	CbGeAlD
Amiloride—SCNN1D—liver—hypothyroidism	0.0065	0.0144	CbGeAlD
Amiloride—SCNN1A—adrenal gland—hypothyroidism	0.00649	0.0144	CbGeAlD
Amiloride—SCNN1A—blood—hypothyroidism	0.00649	0.0144	CbGeAlD
Amiloride—SLC9A1—testis—hypothyroidism	0.00647	0.0143	CbGeAlD
Amiloride—AOC1—liver—hypothyroidism	0.00638	0.0141	CbGeAlD
Amiloride—SCNN1D—cerebellum—hypothyroidism	0.00635	0.0141	CbGeAlD
Amiloride—SCNN1G—cerebellum—hypothyroidism	0.00635	0.0141	CbGeAlD
Amiloride—SCNN1A—thyroid gland—hypothyroidism	0.00627	0.0139	CbGeAlD
Amiloride—ASIC1—cerebellum—hypothyroidism	0.00624	0.0138	CbGeAlD
Amiloride—PLAU—testis—hypothyroidism	0.00613	0.0136	CbGeAlD
Amiloride—SLC9A1—liver—hypothyroidism	0.00611	0.0135	CbGeAlD
Amiloride—SCNN1A—female gonad—hypothyroidism	0.00605	0.0134	CbGeAlD
Amiloride—SLC9A1—cerebellum—hypothyroidism	0.00597	0.0132	CbGeAlD
Amiloride—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00593	0.0267	CbGpPWpGaD
Amiloride—SCNN1B—testis—hypothyroidism	0.00581	0.0129	CbGeAlD
Amiloride—PLAU—liver—hypothyroidism	0.0058	0.0128	CbGeAlD
Amiloride—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00553	0.0249	CbGpPWpGaD
Amiloride—SCNN1A—testis—hypothyroidism	0.00537	0.0119	CbGeAlD
Amiloride—Muscular weakness—Liotrix—hypothyroidism	0.00531	0.0162	CcSEcCtD
Amiloride—Abdominal distension—Liotrix—hypothyroidism	0.00524	0.016	CcSEcCtD
Amiloride—SCNN1A—liver—hypothyroidism	0.00508	0.0112	CbGeAlD
Amiloride—Angina pectoris—Liotrix—hypothyroidism	0.00507	0.0155	CcSEcCtD
Amiloride—Alopecia—Levothyroxine—hypothyroidism	0.005	0.0153	CcSEcCtD
Amiloride—Alopecia—Dextrothyroxine—hypothyroidism	0.005	0.0153	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00495	0.0223	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.0049	0.0221	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00487	0.022	CbGpPWpGaD
Amiloride—Tension—Dextrothyroxine—hypothyroidism	0.00483	0.0148	CcSEcCtD
Amiloride—Tension—Levothyroxine—hypothyroidism	0.00483	0.0148	CcSEcCtD
Amiloride—Nervousness—Levothyroxine—hypothyroidism	0.00479	0.0147	CcSEcCtD
Amiloride—Nervousness—Dextrothyroxine—hypothyroidism	0.00479	0.0147	CcSEcCtD
Amiloride—Tremor—Levothyroxine—hypothyroidism	0.00462	0.0141	CcSEcCtD
Amiloride—Tremor—Dextrothyroxine—hypothyroidism	0.00462	0.0141	CcSEcCtD
Amiloride—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00453	0.0204	CbGpPWpGaD
Amiloride—Palpitations—Dextrothyroxine—hypothyroidism	0.00435	0.0133	CcSEcCtD
Amiloride—Palpitations—Levothyroxine—hypothyroidism	0.00435	0.0133	CcSEcCtD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00435	0.0196	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00422	0.019	CbGpPWpGaD
Amiloride—Arthralgia—Levothyroxine—hypothyroidism	0.00419	0.0128	CcSEcCtD
Amiloride—Arthralgia—Dextrothyroxine—hypothyroidism	0.00419	0.0128	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00419	0.0189	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.0041	0.0185	CbGpPWpGaD
Amiloride—Confusional state—Dextrothyroxine—hypothyroidism	0.00405	0.0124	CcSEcCtD
Amiloride—Confusional state—Levothyroxine—hypothyroidism	0.00405	0.0124	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00403	0.0182	CbGpPWpGaD
Amiloride—Shock—Levothyroxine—hypothyroidism	0.00396	0.0121	CcSEcCtD
Amiloride—Shock—Dextrothyroxine—hypothyroidism	0.00396	0.0121	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00375	0.0169	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00375	0.0169	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00375	0.0169	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00375	0.0169	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00375	0.0169	CbGpPWpGaD
Amiloride—Alopecia—Liotrix—hypothyroidism	0.00368	0.0113	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00366	0.0112	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00366	0.0112	CcSEcCtD
Amiloride—Insomnia—Dextrothyroxine—hypothyroidism	0.00364	0.0111	CcSEcCtD
Amiloride—Insomnia—Levothyroxine—hypothyroidism	0.00364	0.0111	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00362	0.0163	CbGpPWpGaD
Amiloride—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00359	0.011	CcSEcCtD
Amiloride—Dyspnoea—Levothyroxine—hypothyroidism	0.00359	0.011	CcSEcCtD
Amiloride—Flatulence—Liotrix—hypothyroidism	0.00357	0.0109	CcSEcCtD
Amiloride—Tension—Liotrix—hypothyroidism	0.00356	0.0109	CcSEcCtD
Amiloride—Nervousness—Liotrix—hypothyroidism	0.00352	0.0108	CcSEcCtD
Amiloride—SLC22A4—heart—hypothyroidism	0.00349	0.00772	CbGeAlD
Amiloride—Fatigue—Dextrothyroxine—hypothyroidism	0.00347	0.0106	CcSEcCtD
Amiloride—Fatigue—Levothyroxine—hypothyroidism	0.00347	0.0106	CcSEcCtD
Amiloride—Tremor—Liotrix—hypothyroidism	0.0034	0.0104	CcSEcCtD
Amiloride—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00331	0.0101	CcSEcCtD
Amiloride—Feeling abnormal—Levothyroxine—hypothyroidism	0.00331	0.0101	CcSEcCtD
Amiloride—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00329	0.0101	CcSEcCtD
Amiloride—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00329	0.0101	CcSEcCtD
Amiloride—Palpitations—Liotrix—hypothyroidism	0.0032	0.00981	CcSEcCtD
Amiloride—Abdominal pain—Levothyroxine—hypothyroidism	0.00318	0.00973	CcSEcCtD
Amiloride—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00318	0.00973	CcSEcCtD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00311	0.014	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00311	0.014	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00311	0.014	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00311	0.014	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00311	0.014	CbGpPWpGaD
Amiloride—Arthralgia—Liotrix—hypothyroidism	0.00309	0.00945	CcSEcCtD
Amiloride—Chest pain—Liotrix—hypothyroidism	0.00309	0.00945	CcSEcCtD
Amiloride—Confusional state—Liotrix—hypothyroidism	0.00298	0.00913	CcSEcCtD
Amiloride—SLC22A4—pituitary gland—hypothyroidism	0.00291	0.00645	CbGeAlD
Amiloride—Shock—Liotrix—hypothyroidism	0.00291	0.00891	CcSEcCtD
Amiloride—Asthenia—Dextrothyroxine—hypothyroidism	0.00289	0.00883	CcSEcCtD
Amiloride—Asthenia—Levothyroxine—hypothyroidism	0.00289	0.00883	CcSEcCtD
Amiloride—Pruritus—Levothyroxine—hypothyroidism	0.00284	0.00871	CcSEcCtD
Amiloride—Pruritus—Dextrothyroxine—hypothyroidism	0.00284	0.00871	CcSEcCtD
Amiloride—Anorexia—Liotrix—hypothyroidism	0.00282	0.00863	CcSEcCtD
Amiloride—Diarrhoea—Levothyroxine—hypothyroidism	0.00275	0.00842	CcSEcCtD
Amiloride—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00275	0.00842	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—IGF1—hypothyroidism	0.00271	0.0122	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00269	0.00825	CcSEcCtD
Amiloride—Insomnia—Liotrix—hypothyroidism	0.00268	0.00819	CcSEcCtD
Amiloride—Paraesthesia—Liotrix—hypothyroidism	0.00266	0.00813	CcSEcCtD
Amiloride—Dyspnoea—Liotrix—hypothyroidism	0.00264	0.00807	CcSEcCtD
Amiloride—SLC22A4—adrenal gland—hypothyroidism	0.0026	0.00576	CbGeAlD
Amiloride—SLC22A4—blood—hypothyroidism	0.0026	0.00576	CbGeAlD
Amiloride—Decreased appetite—Liotrix—hypothyroidism	0.00257	0.00787	CcSEcCtD
Amiloride—Vomiting—Levothyroxine—hypothyroidism	0.00256	0.00783	CcSEcCtD
Amiloride—Vomiting—Dextrothyroxine—hypothyroidism	0.00256	0.00783	CcSEcCtD
Amiloride—Fatigue—Liotrix—hypothyroidism	0.00255	0.00781	CcSEcCtD
Amiloride—Rash—Dextrothyroxine—hypothyroidism	0.00254	0.00776	CcSEcCtD
Amiloride—Rash—Levothyroxine—hypothyroidism	0.00254	0.00776	CcSEcCtD
Amiloride—Dermatitis—Dextrothyroxine—hypothyroidism	0.00253	0.00775	CcSEcCtD
Amiloride—Dermatitis—Levothyroxine—hypothyroidism	0.00253	0.00775	CcSEcCtD
Amiloride—Constipation—Liotrix—hypothyroidism	0.00253	0.00774	CcSEcCtD
Amiloride—Headache—Levothyroxine—hypothyroidism	0.00252	0.00771	CcSEcCtD
Amiloride—Headache—Dextrothyroxine—hypothyroidism	0.00252	0.00771	CcSEcCtD
Amiloride—SLC22A4—thyroid gland—hypothyroidism	0.00251	0.00556	CbGeAlD
Amiloride—SLC22A1—blood—hypothyroidism	0.00248	0.00548	CbGeAlD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00247	0.0112	CbGpPWpGaD
Amiloride—Feeling abnormal—Liotrix—hypothyroidism	0.00244	0.00746	CcSEcCtD
Amiloride—Gastrointestinal pain—Liotrix—hypothyroidism	0.00242	0.0074	CcSEcCtD
Amiloride—Nausea—Dextrothyroxine—hypothyroidism	0.00239	0.00731	CcSEcCtD
Amiloride—Nausea—Levothyroxine—hypothyroidism	0.00239	0.00731	CcSEcCtD
Amiloride—Abdominal pain—Liotrix—hypothyroidism	0.00234	0.00716	CcSEcCtD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00232	0.0105	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00223	0.01	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00216	0.00975	CbGpPWpGaD
Amiloride—Asthenia—Liotrix—hypothyroidism	0.00212	0.0065	CcSEcCtD
Amiloride—Pruritus—Liotrix—hypothyroidism	0.00209	0.00641	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00205	0.00925	CbGpPWpGaD
Amiloride—Diarrhoea—Liotrix—hypothyroidism	0.00202	0.0062	CcSEcCtD
Amiloride—SLC22A4—cerebellum—hypothyroidism	0.00199	0.0044	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00198	0.00893	CbGpPWpGaD
Amiloride—Dizziness—Liotrix—hypothyroidism	0.00196	0.00599	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00195	0.00878	CbGpPWpGaD
Amiloride—SLC22A1—liver—hypothyroidism	0.00194	0.00429	CbGeAlD
Amiloride—Vomiting—Liotrix—hypothyroidism	0.00188	0.00576	CcSEcCtD
Amiloride—Rash—Liotrix—hypothyroidism	0.00187	0.00571	CcSEcCtD
Amiloride—Dermatitis—Liotrix—hypothyroidism	0.00186	0.0057	CcSEcCtD
Amiloride—Headache—Liotrix—hypothyroidism	0.00185	0.00567	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00185	0.00833	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.00182	0.00823	CbGpPWpGaD
Amiloride—Nausea—Liotrix—hypothyroidism	0.00176	0.00538	CcSEcCtD
Amiloride—SLC9A1—Metabolism—IYD—hypothyroidism	0.00167	0.00754	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00156	0.00703	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00153	0.00691	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.0015	0.00676	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.0015	0.00676	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.0015	0.00676	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.0015	0.00676	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.0015	0.00676	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ATP5O—hypothyroidism	0.00142	0.00641	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TPO—hypothyroidism	0.00134	0.00603	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0013	0.00586	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SH2B3—hypothyroidism	0.00123	0.00553	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00121	0.00546	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00118	0.00533	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00118	0.00533	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00118	0.00533	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00118	0.00533	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00118	0.00533	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00113	0.00511	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00105	0.00475	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000996	0.00449	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000989	0.00446	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000982	0.00443	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000938	0.00423	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000928	0.00419	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00089	0.00402	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000873	0.00394	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VAV3—hypothyroidism	0.000842	0.0038	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000837	0.00378	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000814	0.00367	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000781	0.00352	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000778	0.00351	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000701	0.00316	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000642	0.00289	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TSHB—hypothyroidism	0.000619	0.00279	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000598	0.0027	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3C2A—hypothyroidism	0.000551	0.00249	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000535	0.00241	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—hypothyroidism	0.000518	0.00234	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000499	0.00225	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRL—hypothyroidism	0.000488	0.0022	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC5A5—hypothyroidism	0.000463	0.00209	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000452	0.00204	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000444	0.002	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000421	0.0019	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000413	0.00187	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000392	0.00177	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IYD—hypothyroidism	0.000362	0.00163	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000356	0.00161	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IYD—hypothyroidism	0.000337	0.00152	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000332	0.0015	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000309	0.00139	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000308	0.00139	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TPO—hypothyroidism	0.000289	0.0013	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ATP5O—hypothyroidism	0.000287	0.00129	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TPO—hypothyroidism	0.00027	0.00122	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—hypothyroidism	0.000242	0.00109	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000214	0.000965	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000199	0.0009	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000168	0.00076	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000157	0.000708	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TSHB—hypothyroidism	0.000134	0.000604	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TSHB—hypothyroidism	0.000125	0.000563	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	0.000119	0.000538	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	0.000111	0.000502	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—hypothyroidism	0.0001	0.000452	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—hypothyroidism	9.34e-05	0.000421	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—hypothyroidism	5.24e-05	0.000237	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—hypothyroidism	4.89e-05	0.00022	CbGpPWpGaD
